Federal policy makers are talking once again about reforming the healthcare system in the U.S. – and this time, it looks like they mean business. This wave of change will force healthcare marketers – in big pharma, in HMOs and other provider organizations, and in medical device manufacturers of all kinds – to rethink their brands, their customer relationships and their media choices in fundamental ways.
Continue reading →